Improvement in Cognitive Processing Speed with Ofatumumab in Patients with Relapsing Multiple Sclerosis

被引：0
|
作者：
Benedict, R. H. B. [1 ]
Penner, I. -K. [2 ]
Cutter, G. [3 ]
Kappos, L. [4 ,5 ,6 ,7 ,8 ,9 ]
Coyle, P. K. [10 ]
Piani-Meier, D. [11 ]
Azmon, A. [11 ]
Boer, I. [11 ]
Su, W. [12 ]
Cohen, J. [13 ]
机构：
[1] Univ Buffalo, Dept Neurol, Buffalo, NY USA
[2] Heinrich Heine Univ, COGITO Ctr Appl Neurocognit & Neuropsychol Res, Dept Neurol, Med Fac, Dusseldorf, Germany
[3] UAB Sch Publ Hlth, Birmingham, AL USA
[4] Univ Hosp, Res Ctr Clin Neuroimmunol & Neurosci Basel, Basel, Switzerland
[5] Univ Hosp, MS Ctr, Dept Head Spine & Neuromed, Basel, Switzerland
[6] Univ Hosp, MS Ctr, Dept Clin Res, Basel, Switzerland
[7] Univ Hosp, MS Ctr, Dept Biomed, Basel, Switzerland
[8] Univ Hosp, MS Ctr, Dept Biomed Engn, Basel, Switzerland
[9] Univ Basel, Basel, Switzerland
[10] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA
[11] Novartis Pharma AG, Basel, Switzerland
[12] Novartis Pharmaceut, E Hanover, NJ USA
[13] Cleveland Clin, Neurol Inst, Dept Neurol, Mellen MS Ctr, Cleveland, OH 44106 USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
OPR-130
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [31] Change in cognitive processing speed is associated with cortical grey matter and thalamic volume loss in patients with relapsing-remitting multiple sclerosis
    Benedict, Ralph H. B.
    Arnold, Douglas L.
    Rose, John
    Cohan, Stanley
    Lynch, Sharon
    Kappos, Ludwig
    Havrdova, Eva K.
    Khatri, Bhupendra
    Su, Ray
    Naylor, Maria
    Kieseier, Bernd
    Giovannoni, Gavin
    NEUROLOGY, 2020, 94 (15)
  • [32] Ozanimod-treated patients exhibited improvements in cognitive processing speed in the phase 3 SUNBEAM trial of relapsing multiple sclerosis (RMS)
    Deluca, J.
    Huang, D.
    Cohen, J. A.
    Cree, B. A. C.
    Chen, Y.
    Campagnolo, D.
    Sheffield, J. K.
    Comi, G.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 263 - 264
  • [33] Baseline Cognition and Magnetic Resonance Imaging Measures of Patients With Relapsing Multiple Sclerosis in ENLIGHTEN: a Study of the Effect of Ozanimod on Cognitive Processing Speed
    DeLuca, J.
    Riolo, J. V.
    Cheng, C.
    Naismith, R. T.
    Wray, S.
    Bass, A. D.
    Fox, E.
    Riser, E.
    Chaudhry, B.
    Silva, D.
    Zivadinov, R.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 49 - 50
  • [34] Change in cognitive processing speed is associated with cortical grey matter and thalamic volume loss in patients with relapsing-remitting multiple sclerosis
    Benedict, R. H.
    Arnold, D. L.
    Rose, J.
    Cohan, S.
    Lynch, S. G.
    Kappos, L.
    Havrdova, E. K.
    Khatri, B.
    Su, R.
    Naylor, M. L.
    Kieseier, B. C.
    Giovannoni, G.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 177 - 178
  • [35] Long-term Effect of Ofatumumab on Serum Immunoglobulin Levels in Patients With Relapsing Multiple Sclerosis
    Wiendl, Heinz
    de Seze, Jerome
    Bar-Or, Amit
    Correale, Jorge
    Cross, Anne
    Derfuss, Tobias
    Selmaj, Krzysztof
    Winthrop, Kevin
    Giacomini, Paul
    Sacca, Francesco
    Hu, Xixi
    Sullivan, Roseanne
    Jehl, Valentine
    Boer, Ibolya
    Bhatt, Alit
    Hauser, Stephen
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 612 - 613
  • [36] Author response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
    Bar-Or, Amit
    Grove, Richard A.
    Tolson, Jerry M.
    Derosier, Frederick J.
    Lopez, Monica C.
    Kavanagh, Sarah T.
    Miller, Aaron E.
    NEUROLOGY, 2019, 92 (11) : 543 - 543
  • [37] COST-EFFECTIVENESS OF OFATUMUMAB IN TREATMENT OF RELAPSING MULTIPLE SCLEROSIS IN TURKEY
    Tatar, M.
    Yarci, B.
    Akdemir, A. C.
    Olmez, C.
    Tinaz, E.
    Turanli, M.
    VALUE IN HEALTH, 2023, 26 (12) : S148 - S148
  • [38] COST-EFFECTIVENESS OF OFATUMUMAB VERSUS OCRELIZUMAB IN PATIENTS WITH ACTIVE RELAPSING MULTIPLE SCLEROSIS IN PORTUGAL
    Goncalves, N.
    Esparteiro, J.
    Machado, M.
    Ferreira, C.
    Guerreiro, T.
    VALUE IN HEALTH, 2022, 25 (12) : S78 - S78
  • [39] Ofatumumab Dose Selection in Pediatric Population with Relapsing Multiple Sclerosis (RMS)
    Skataric, Maja
    Savelieva, Marina
    Pigeolet, Etienne
    Leppert, David
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S86 - S86
  • [40] Reader response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
    Kearney, Hugh
    NEUROLOGY, 2019, 92 (11) : 542 - 543
12345